{
    "nctId": "NCT02152696",
    "officialTitle": "Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location - a Randomized Clinical Trial of Women at Risk for an Ectopic Pregnancy: Active Treatment Versus No Treatment",
    "inclusionCriteria": "* Female with a persisting pregnancy of unknown location:\n* A pregnancy of unknown location is defined as a pregnancy in a woman with a positive pregnancy test but no definitive signs of pregnancy in the uterus or adnexa on ultrasound imaging. A definitive sign of gestation includes ultrasound visualization of a gestational sac with a yolk sac (with or without an embryo) in the uterus or in the adnexa. Ultrasound must be performed within 7 days prior to randomization.\n* Persistence of hCG is defined as at least 2 serial hCG values (over 2-14 days), showing \\< 15% rise per day, or \\< 50% fall between the first and last value.\n* Patient is hemodynamically stable, hemoglobin \\>10 mg/dL\n* Greater than or 18 years of age\n* Must be FEMALE\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* Hemodynamically unstable in need of acute treatment\n* Most recent hCG \\> 5000 mIU/mL\n* Patient obtaining care in relation to a recently completed pregnancy (delivery, spontaneous or elective abortion)\n* Diagnosis of gestational trophoblastic disease\n* Subject unwilling or unable to comply with study procedures\n* Known hypersensitivity to MTX\n* Presence of clinical contraindications for treatment with MTX\n* Prior medical or surgical management of this gestation\n* Subject unwilling to accept a blood transfusion"
}